{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:13:35Z","timestamp":1788776015431,"version":"build-2803163510"},"reference-count":38,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Experimental Hypertension"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/10641963.2026.2725928","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:07:09Z","timestamp":1788775629000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Associations of antihypertensive medication class with liver fibrosis and mortality in US adults with MASLD"],"prefix":"10.1080","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7348-565X","authenticated-orcid":false,"given":"Yu","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Hepatology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine","place":["Shanghai, People's Republic of China"]},{"name":"Department of Pharmacology, Yale School of Medicine","place":["New Haven, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Decision and Information Sciences, School of Business Administration, Oakland University","place":["Rochester, USA"]},{"name":"Department of Biostatistics, Yale School of Public Health, Yale University","place":["New Haven, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"e_1_3_9_2_1","first-page":"S10432760240003","article-title":"Current status and future trends of the global burden of MASLD","author":"Miao L","year":"2024","unstructured":"Miao L , Targher G , Byrne CD , Cao YY , Zheng MH . Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024 February. S1043276024000365.","journal-title":"Trends Endocrinol Metab"},{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00759-2"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.21019"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017"},{"key":"e_1_3_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2023.11.012"},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0140"},{"key":"e_1_3_9_8_1","first-page":"S01688278250245","article-title":"Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD","author":"Zhou X-D","year":"2025","unstructured":"Zhou X-D , Lian L-Y , Chen Q-F , Kim SU , Yip TC-F , Petta S , Nakajima A , Tsochatzis E , Shi J , Chan W-K , et al. Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD. J Hepatol. 2025 August. S0168827825024535.","journal-title":"J Hepatol"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000735"},{"key":"e_1_3_9_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001333"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115807"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14669"},{"key":"e_1_3_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.09.014"},{"key":"e_1_3_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.12.015"},{"key":"e_1_3_9_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330595"},{"key":"e_1_3_9_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000935"},{"key":"e_1_3_9_17_1","doi-asserted-by":"publisher","DOI":"10.2337\/cd22-as01"},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066"},{"key":"e_1_3_9_19_1","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of The National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third report of The National cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143\u20133421.","journal-title":"Circulation"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0506"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0392"},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27368"},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.1515\/jci-2014-0039"},{"key":"e_1_3_9_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000925"},{"key":"e_1_3_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155800"},{"key":"e_1_3_9_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-019-0247-5"},{"key":"e_1_3_9_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63058-z"},{"key":"e_1_3_9_29_1","article-title":"Epidemiology of metabolic dysfunction associated steatotic liver disease","author":"Younossi ZM","year":"2024","unstructured":"Younossi ZM , Kalligeros M , Henry L . Epidemiology of metabolic dysfunction associated steatotic liver disease. Clin Mol Hepatol. 2024 August.","journal-title":"Clin Mol Hepatol"},{"key":"e_1_3_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12090"},{"key":"e_1_3_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.12.031"},{"key":"e_1_3_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12611"},{"key":"e_1_3_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.07.009"},{"key":"e_1_3_9_34_1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0237"},{"key":"e_1_3_9_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11065"},{"key":"e_1_3_9_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-022-01117-6"},{"key":"e_1_3_9_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29113"},{"key":"e_1_3_9_38_1","doi-asserted-by":"publisher","DOI":"10.35946\/arcr.v38.1.05"},{"key":"e_1_3_9_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000604"}],"container-title":["Clinical and Experimental Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10641963.2026.2725928","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10641963.2026.2725928","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10641963.2026.2725928","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:07:10Z","timestamp":1788775630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10641963.2026.2725928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/10641963.2026.2725928"],"URL":"https:\/\/doi.org\/10.1080\/10641963.2026.2725928","relation":{},"ISSN":["1064-1963","1525-6006"],"issn-type":[{"value":"1064-1963","type":"print"},{"value":"1525-6006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iceh20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iceh20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2725928"}}